the aid library

LIST OPTIONS

Filter

4379

Guide for clinical case management and infection prevention and control during a measles outbreak

World Health Organization WHO (2020) C_WHO

Guide for clinical case management and infection prevention and control during ameasles outbreak. This guide has been developed to reduce the high morbidity and mortality seen in some of the current outbreaks of measles. This short guide outlines practical clinical care interventions and is derived ... more

Download (177)

View PDF (225)

Therapeutics for Ebola virus disease
recommended

World Health Organization WHO (2022) C_WHO

The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il... more

External Link

Palliative Care Toolkits and Training Manual
recommended

Worldwide Hospice Palliative Care Alliance (2014) CC

This toolkit has been written to empower health workers in resource-poor settings to integrate palliative care into the work they are doing by grafting the missing elements of care onto what is already in place. The WHPCA, Hospice UK and Palliative Care Works have led this updating of the Palliative... more

Download (987)

View PDF (2259)

Ebola: Beyond the health emergency

Plan (2015)

Summary of research into the consequences of the Ebola outbreak for children and communities in Liberia and Sierra Leone This study describes the range of impacts that Ebola has had on children and families in Liberia and Sierra Leone, looking beyond the immediate health effects

Download (653)

View PDF (1049)

Care of girls and women living with female genital mutilation

World Health Organization WHO (2018) C_WHO

This handbook is for health care providers involved in the care of girls and women who have been subjected to any form of female genital mutilation (FGM). This includes obstetricians and gynaecologists, surgeons, general medical practitioners, midwives, nurses and other country-specific health profe... more

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (539)

View PDF (378)

An Assessment of Available Evidence on NCDs and their Risk Factors in Myanmar

HelpAge International Myanmar, University of Public Health and University of Medicine-2 (2016) C1

Report on Main Findings
The review encompasses three complementary components: 1) a review of published literature 2000-2015 on NCDs and their risk factors; 2) qualitative interviews with key actors engaged in NCD research in Myanmar; and 3) additional reviews of Myanmar ethical committee inqui... more

Download (2481)

View PDF (5093)

The Good Enough Guide
recommended

Emergency Capacity Building Project Oxfam (2007) C1

A set of basic guidelines on how to be accountable to local people and measure program impact in emergency situations. The "good enough" approach emphasizes simple and practical solutions and encourages the user to choose tools that are safe, quick, and easy to implement

Download (339)

View PDF (343)

Tuberculosis (TB)
recommended

Reijer, P.; and S. Mauder (2022) CC

MEDBOX Issue Brief no. 19: World TB Day: Invest to end TB. Save Lives

Download (287)

View PDF (590)

New Pathways for Childhood TB Treatment

Unitaid; TB Alliance (2017) C2

Lessons from the STEP-TB Project. Accessed November 2017.

External Link

New hope for leishmaniasis

Drugs for Neglected Diseases initiative DNDi (2022) CC

Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para... more

Download (1353)

View PDF (1780)

World Health Organization model list of essential medicines for children: 8th list
recommended

World Health Organization WHO (2021) C_WHO

WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.

Download (587)

View PDF (563)

Eliminate Yellow fever Epidemics (EYE): a global strategy, 2017-2026

World Health Organization WHO (2018) C_WHO

The EYE strategy is a comprehensive and long-term strategy built on lessons learned that aims at ending yellow fever epidemics by 2026, and consists of three strategic objectives: protect at-risk populations; prevent international spread; and contain outbreaks rapidly.

Download (159)

View PDF (171)

Tuberculosis Research Funding Trends 2005-2020

World Health Organisation (WHO) (2021) C_WHO

Previous advocacy efforts have achieved tangible goals in terms garnering political commitments to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge now is to ensure that these commitments are actually met within a global biomedical research ecosystem that... more

External Link

2 millions d’agents de santé communautaires en Afrique

Inconnu (2020) C2

Accessed on 13.02.2020 Tirer pleinement profit du dividende démographique, mettre fin à l’épidémie de sida et assurer durablement la santé pour tous en Afrique. Ce rapport plaide pour une nouvelle initiative majeure : recruter, former et déployer rapidement 2 millions d’agents de s... more

Download (239)

View PDF (228)

Nigeria Country Office 2021 Annual Report

World Health Organization WHO (2022) C_WHO

This annual report highlights the work of the WHO from January to June 2021 ( December 2021). The activities featured herein are by no means exhausted but implemented with technical and financial support through WHO in Nigeria; facilitated by its presence at all levels of governance (national, state... more

Download (153)

View PDF (151)

Kenya Cancer Policy 2019 - 2030

Republic of Kenya, Ministry of Health (2020) CC

Globally, the cancer burden is rising, exerting significant strain on populations and health systems at all levels of income. There are concerted efforts towards enhancing access to comprehensive cancer prevention and control initiatives.

Download (463)

View PDF (593)

Tracking aid for the WHA nutrition targets: Global spending in 2015 and a roadmap to better data

Alimonte, Mary D'; Thacher, Emily; LeMier, Ryan; Clift, Jack Results for Development (R4D) (2018) C1

In 2017, the World Bank and partners created the Global Investment Framework for Nutrition as a roadmap towards achieving the World Health Assembly (WHA) nutrition targets by 2025. The framework estimates that the world needs to mobilize an annual additional investment of $7 billion per year to scal... more